Book Chapters

• James, M., Strasser, S. (2009). Management of advanced liver disease. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 330-351). East Hawthorn, Victoria: IP Communications.

Journals

• Vidot, H., Teevan, K., Carey, S., Strasser, S., Shackel, N. (2016). A prospective audit of preprocedural fasting practices on a transplant ward: When fasting becomes starving. Journal of Clinical Nursing, 25(5-6), 829-835. [More Information]
• Najjar, Z., Gupta, L., Pritchard-Jones, J., Strasser, S., Levy, M., Liaw, S., Cowle, B. (2016). A survey of Sydney general practitioners' management of patients with chronic hepatitis B. Medical Journal of Australia, 204(2), 74.e1-74.e4.
• McCaughan, G., Crawford, M., Sandroussi, C., Koorey, D., Bowen, D., Shackel, N., Strasser, S. (2016). Assessment of adult patients with chronic liver failure for liver transplantation in 2015: who and when? Internal Medicine Journal, 46(4), 404-412. [More Information]
• Marcellin, P., Ahn, S., Ma, X., Caruntu, F., Tak, W., Elkashab, M., Chuang, W., Lim, S., Tabak, F., Mehta, R., Strasser, S., et al (2016). Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B. Gastroenterology, 150(1), 134-144.e10. [More Information]
• Visvanathan, K., Dusheiko, G., Giles, M., Wong, M., Phung, N., Walker, S., Le, S., Lim, S., Strasser, S., et al (2016). Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut (English Edition): an international journal of gastroenterology and hepatology, 65(2), 340-350. [More Information]
• Vongsuvanh, R., van der Poorten, D., Iseli, T., Strasser, S., McCaughan, G., George, J. (2016). Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. PloS One, 11(5), 1-12. [More Information]
• Doyle, A., Marsh, P., Gill, R., Rodov, M., Mohsen, W., Varma, P., Hong, T., Strasser, S., Bell, S., Ryan, M., et al (2016). Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study. Scandinavian Journal of Gastroenterology, 51(8), 979-985. [More Information]
• Howell, J., Balderson, G., Hellard, M., Gow, P., Strasser, S., Stuart, K., Wigg, A., Jeffrey, G., Gane, E., Angus, P. (2016). The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand. Journal of Gastroenterology and Hepatology, 31(2), 434-441. [More Information]
• Rahman, W., Tu, T., Budzinska, M., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Warner, F., Bowden, D., Thomspon, A., Bowen, D., Strasser, S., Sharland, A., Yang, J., McCaughan, G., Shackel, N., et al (2015). Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of differentiation Antibody Microarrays. Transplantation, 99(9), e120-e126. [More Information]
• Dore, G., Lawitz, E., Hezode, C., Shafran, S., Ramji, A., Tatum, H., Taliani, G., Tran, A., Strasser, S., George, J., et al (2015). Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection. Gastroenterology, 148(2), 355-366. [More Information]
• Pritchard-Jones, J., Stevens, C., McCaughan, G., Strasser, S. (2015). Feasibility, acceptability and safety of a nurse led hepatitis B clinic based in the community. Collegian, 22(2), 233-240. [More Information]
• Lepida, A., Colombo, M., Fernandez, I., Abdurakhmanov, D., Abrao Ferreira, P., Strasser, S., Urbanek, P., Mangia, A., Calleja, F., Iraqi, W., et al (2015). Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis. PloS One, 10(9), 1-15. [More Information]
• Pulitano, C., Joseph, D., Sandroussi, C., Verran, D., Strasser, S., Shackel, N., McCaughan, G., Crawford, M. (2015). Hepatic Artery Stenosis After Liver Transplantation: Is Endovascular Treatment Always Necessary? Liver Transplantation, 21(2), 162-168. [More Information]
• McCaughan, G., Sze, K., Strasser, S. (2015). Is there such a thing as protocol immunosuppression in liver transplantation? Expert Review of Gastroenterology and Hepatology, 9(1), 1-4. [More Information]
• Pianko, S., Flamm, S., Shiffman, M., Kumar, S., Strasser, S., Dore, G., Mcnally, J., Brainard, D., Han, L., Doehle, B., et al (2015). Sofosbuvir plus velpatasvir combination therapy for treatment- Experienced patients with genotype 1 or 3 hepatitis c virus infection: A randomized trial. Annals of Internal Medicine, 163(11), 809-817. [More Information]
• Kitzing, Y., Ng, B., Kitzing, B., Waugh, R., Kench, J., Strasser, S., McCormack, S. (2015). Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population. Journal of Medical Imaging and Radiation Oncology, 59(6), 673-680. [More Information]
• Nguyen, V., Tan, P., Greenup, A., Glass, A., Davison, S., Samarasinghe, D., Holdaway, S., Strasser, S., Chatterjee, U., Jackson, K., et al (2014). Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Alimentary Pharmacology and Therapeutics, 39(10), 1225-1234. [More Information]
• Chinnaratha, M., Chelvaratnam, U., Stuart, K., Strasser, S., McCaughan, G., Gow, P., Adams, L., Wigg, A. (2014). Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders. Liver Transplantation, 20(7), 798-806. [More Information]
• Strasser, S. (2014). Managing hepatitis B to prevent liver cancer: recent advances. Expert Review of Gastroenterology and Hepatology, 8(4), 409-415. [More Information]
• Davison, S., Strasser, S. (2014). Ordering and interpreting hepatitis B serology. BMJ, 348, g2522. [More Information]
• Colombo, M., Fernandez, I., Abdurakhmanov, D., Ferreira, P., Strasser, S., Urbanek, P., Moreno, C., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C. Gut (English Edition): an international journal of gastroenterology and hepatology, 63(7), 1150-1158. [More Information]
• Colombo, M., Strasser, S., Moreno, C., Abrao Ferreira, P., Urbanek, P., Fernandez, I., Abdurakmonov, D., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Sustained Virological Response with Telaprevir in 1078 Patients With Advanced Hepatitis C: The International Telaprevir Access Program. Journal of Hepatology, 61(5), 976-983. [More Information]
• Roberts, D., Hall, M., Falkland, M., Strasser, S., Buckley, N. (2013). Amanita phalloides poisoning and treatment with silibinin in the Australian Capital Territory and New South Wales. Medical Journal of Australia, 198(1), 43-47. [More Information]
• Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Author reply: RE Terlipressin therapy for moderate to severe hyponatraemia in patients with liver failure. Internal Medicine Journal, 43(5), 607-607. [More Information]
• Gane, E., Patterson, S., Strasser, S., McCaughan, G., Angus, P. (2013). Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transplantation, 19(3), 268-274. [More Information]
• Strasser, S. (2013). Hepatocellular carcinoma: The most rapidly rising cause of cancer death in Australia. Medicine Today, 14(12), 55-57.
• Silva, M., Strasser, S., Carrilho, F. (2013). Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma? Clinics, 68(4), 437-440. [More Information]
• Silva, M., Sapisochin, G., Strasser, S., Hewa-Geeganage, S., Chen, J., Wigg, A., Jones, R., Saraiva, R., Kikuchi, L., Carrilho, F., et al (2013). Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysis. European Journal of Surgical Oncology, 39(4), 386-395. [More Information]
• Saunderson, R., Garsia, R., Headley, A., McCaughan, G., O'Toole, S., Strasser, S. (2013). Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. Journal of Dermatological Case Reports, 7(3), 77-81. [More Information]
• Gracey, D., Snelling, P., McKenzie, P., Strasser, S. (2013). Tenofovir-associated Fanconi Syndrome in patients with chronic hepatitis B monoinfection. Antiviral Therapy, 18(7), 945-948. [More Information]
• Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Terlipressin Therapy for Moderate to Severe Hyponatremia in Patients with Liver Failure. Internal Medicine Journal, 43(3), 240-246. [More Information]
• Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012). Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International, 32(10), 1527-1534. [More Information]
• Strasser, S. (2012). Another achievement in organ transplantation in Australia - yet much still needs to be done. Medical Journal of Australia, 197(8), 429-430. [More Information]
• Strasser, S. (2012). Drugs in Development for the Treatment of Chronic Hepatitis B. Current Hepatology Reports, 11(2), 111-118. [More Information]
• Graaf, E., Kench, J., Dilworth, P., Shackel, N., Strasser, S., Joseph, D., Pleass, H., Crawford, M., McCaughan, G., Verran, D. (2012). Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. Journal of Gastroenterology and Hepatology, 27(3), 540-546. [More Information]
• Poustchi, H., Farrell, G., Strasser, S., Lee, A., McCaughan, G., George, J. (2011). Feasibility of conducting a randomised control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology, 54(6), 1998-2004. [More Information]
• Strasser, S., Vidot, H. (2011). Nutritional considerations in end-stage liver disease. Journal of Gastroenterology and Hepatology, 26(9), 1346-1348. [More Information]
• Gidding, H., Law, M., Amin, J., Macdonald, G., Sasadeusz, J., Jones, T., Strasser, S., George, J., Dore, G. (2011). Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Medical Journal of Australia, 194(8), 398-402. [More Information]
• Prakoso, E., Verran, D., Dilworth, P., Kyd, G., Tang, P., Tse, C., Koorey, D., Strasser, S., Stormon, M., Shun, A., Allen, R., et al (2010). Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Internal Medicine Journal, 40(9), 619-625. [More Information]
• Nightingale, S., O'Loughlin, E., Dorney, S., Shun, A., Verran, D., Strasser, S., McCaughan, G., Jermyn, V., Van Asperen, P., Gaskin, K., Stormon, M. (2010). Isolated liver transplantation in children with cystic fibrosis - An Australian experience. Pediatric Transplantation, 14(6), 779-785. [More Information]
• Mahady, S., Carlton, B., FitzGerald, P., Koorey, D., Perry, J., Waugh, R., McCaughan, G., Strasser, S. (2010). Locoregional therapies for hepatocellular carcinoma: Which patients are most likely to gain a survival advantage? Journal of Gastroenterology and Hepatology, 25(7), 1299-1305. [More Information]
• McCaughan, G., Shackel, N., Strasser, S., Dilworth, P., Tang, P. (2010). Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transplantation, 16(2), 130-137. [More Information]
• Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., Locarnini, S., Bowden, S., et al (2010). Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut (English Edition): an international journal of gastroenterology and hepatology, 60(2), 247-254. [More Information]
• Sandroussi, C., Crawford, M., Lockwood, D., Tang, P., Gallagher, J., Pleass, H., Strasser, S., Shackel, N., McCaughan, G., Verran, D. (2009). Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients. Liver Transplantation, 15(11), 1586-1593. [More Information]
• Shackel, N., Jamias, J., Rahman, W., Prakoso, E., Strasser, S., Koorey, D., Crawford, M., Verran, D., Gallagher, J., McCaughan, G. (2009). Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C-Related Liver Failure Post-Liver Transplantation. Liver Transplantation, 15(7), 709-718. [More Information]
• Geenen, I., Sosef, M., Shun, A., Crawford, M., Gallagher, J., Strasser, S., Stormon, M., McCaughan, G., Verran, D. (2009). Usage and Outcomes of Deceased Donor Liver Allografts with Preprocurement Injury from Blunt Trauma. Liver Transplantation, 15(3), 321-325. [More Information]
• Angus, P., Patterson, S., Strasser, S., McCaughan, G., Gane, E. (2008). A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis. Hepatology, 48(5), 1460-1466. [More Information]
• Alghamdi, H., Crawford, M., Gallagher, J., McCaughan, G., Strasser, S., Verran, D. (2008). Cadaveric liver transplant from older donors. Saudi Medical Journal, 29(4), 533-538. [More Information]
• Strasser, S. (2008). When should liver biopsy be performed after hematopoietic stem cell transplantation? Journal of Gastroenterology and Hepatology, 23(2), 167-169. [More Information]
• van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
• Labio, E., Del Rosario, D., Strasser, S., McCaughan, G., Crawford, B. (2007). Effect of Ascites on Bone Density Measurement in Cirrhosis. Journal of Clinical Densitometry: Assessment of Skeletal Health, 10(4), 391-394. [More Information]
• Chiong, M., Bennetts, B., Strasser, S., Wilcken, B. (2007). Fatal late-onset ornithine transcarbamylase deficiency after coronary artery bypass surgery. Medical Journal of Australia, 186(8), 418-419. [More Information]
• Perry, J., Charlton, B., Koorey, D., Waugh, R., Gallagher, P., Crawford, M., Verran, D., McCaughan, G., Strasser, S. (2007). Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International, 27(9), 1240-1248. [More Information]
• Salmond, S., George, J., Strasser, S., Batey, R. (2006). Hep573 study of complementary medicine for chronic hepatitis C. Journal Of Clinical Virology, 36(Supplement 2), S134-S135.
• Loss, M., Ng, W., Karim, R., Strasser, S., Koorey, D., Gallagher, P., Verran, D., McCaughan, G. (2006). Hereditary lysozyme amyloidosis: Spontaneous hepatic rupture (15 years apart) in mother and daughter. Role of emeregency liver transplantation. Liver Transplantation, 12(7), 1152-1155. [More Information]
• St George, A., Johnston, A., Bauman, A., Iverson, D., Tapsell, L., McCaughan, G., Strasser, S., McGrath, L., Green, J., Farrell, G., George, J. (2006). Lifestyle intervention in early liver disease: metabolic changes at 3 months. Journal of Gastroenterology and Hepatology, 21(Suppl. 4), A315.
• Prakoso, E., Strasser, S., Koorey, D., Verran, D., McCaughan, G. (2006). Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation, 20(3), 369-373. [More Information]
• Crawford, B., Labio, E., Strasser, S., McCaughan, G. (2006). Vitamin D replacement for cirrhosis-related bone disease. Nature Clinical Practice Gastroenterology and Hepatology, 3(12), 689-699. [More Information]
• Perry, J., Poustchi, H., George, J., Farrell, G., McCaughan, G., Strasser, S. (2005). Current approaches to the diagnosis and management of hepatocellular carcinoma. Clinical and Experimental Medicine, 5(1), 1-13. [More Information]
• McCaughan, G., Koorey, D., Strasser, S. (2005). Liver transplantation for viral hepatitis. British Journal of Hospital Medicine, 66(1), 8-12. [More Information]
• Samuel, D., Riordan, S., Strasser, S., Kurtovic, J., Singh-Grewel, I., Koorey, D. (2004). Severe Autoimmune Hepatitis First Presenting In The Early Post Partum Period. Clinical Gastroenterology and Hepatology, 2(7), 622-624.
• Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., McCaughan, G. (2003). Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplantation, 9(5), 500-505.
• Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive transfer of nut allergy after liver transplantation. Archives of Internal Medicine, 163(2), 237-239.
• Perry, J., Strasser, S., George, J., Farrell, G., McCaughan, G. (2003). Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy, 4(12), 2175-2185.
• McCaughan, G., Koorey, D., Strasser, S. (2002). Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal, 32(8), 394-400.

2016

• Vidot, H., Teevan, K., Carey, S., Strasser, S., Shackel, N. (2016). A prospective audit of preprocedural fasting practices on a transplant ward: When fasting becomes starving. Journal of Clinical Nursing, 25(5-6), 829-835. [More Information]
• Najjar, Z., Gupta, L., Pritchard-Jones, J., Strasser, S., Levy, M., Liaw, S., Cowle, B. (2016). A survey of Sydney general practitioners' management of patients with chronic hepatitis B. Medical Journal of Australia, 204(2), 74.e1-74.e4.
• McCaughan, G., Crawford, M., Sandroussi, C., Koorey, D., Bowen, D., Shackel, N., Strasser, S. (2016). Assessment of adult patients with chronic liver failure for liver transplantation in 2015: who and when? Internal Medicine Journal, 46(4), 404-412. [More Information]
• Marcellin, P., Ahn, S., Ma, X., Caruntu, F., Tak, W., Elkashab, M., Chuang, W., Lim, S., Tabak, F., Mehta, R., Strasser, S., et al (2016). Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B. Gastroenterology, 150(1), 134-144.e10. [More Information]
• Visvanathan, K., Dusheiko, G., Giles, M., Wong, M., Phung, N., Walker, S., Le, S., Lim, S., Strasser, S., et al (2016). Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut (English Edition): an international journal of gastroenterology and hepatology, 65(2), 340-350. [More Information]
• Vongsuvanh, R., van der Poorten, D., Iseli, T., Strasser, S., McCaughan, G., George, J. (2016). Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. PloS One, 11(5), 1-12. [More Information]
• Doyle, A., Marsh, P., Gill, R., Rodov, M., Mohsen, W., Varma, P., Hong, T., Strasser, S., Bell, S., Ryan, M., et al (2016). Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study. Scandinavian Journal of Gastroenterology, 51(8), 979-985. [More Information]
• Howell, J., Balderson, G., Hellard, M., Gow, P., Strasser, S., Stuart, K., Wigg, A., Jeffrey, G., Gane, E., Angus, P. (2016). The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand. Journal of Gastroenterology and Hepatology, 31(2), 434-441. [More Information]

2015

• Rahman, W., Tu, T., Budzinska, M., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Warner, F., Bowden, D., Thomspon, A., Bowen, D., Strasser, S., Sharland, A., Yang, J., McCaughan, G., Shackel, N., et al (2015). Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of differentiation Antibody Microarrays. Transplantation, 99(9), e120-e126. [More Information]
• Dore, G., Lawitz, E., Hezode, C., Shafran, S., Ramji, A., Tatum, H., Taliani, G., Tran, A., Strasser, S., George, J., et al (2015). Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection. Gastroenterology, 148(2), 355-366. [More Information]
• Pritchard-Jones, J., Stevens, C., McCaughan, G., Strasser, S. (2015). Feasibility, acceptability and safety of a nurse led hepatitis B clinic based in the community. Collegian, 22(2), 233-240. [More Information]
• Lepida, A., Colombo, M., Fernandez, I., Abdurakhmanov, D., Abrao Ferreira, P., Strasser, S., Urbanek, P., Mangia, A., Calleja, F., Iraqi, W., et al (2015). Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis. PloS One, 10(9), 1-15. [More Information]
• Pulitano, C., Joseph, D., Sandroussi, C., Verran, D., Strasser, S., Shackel, N., McCaughan, G., Crawford, M. (2015). Hepatic Artery Stenosis After Liver Transplantation: Is Endovascular Treatment Always Necessary? Liver Transplantation, 21(2), 162-168. [More Information]
• McCaughan, G., Sze, K., Strasser, S. (2015). Is there such a thing as protocol immunosuppression in liver transplantation? Expert Review of Gastroenterology and Hepatology, 9(1), 1-4. [More Information]
• Pianko, S., Flamm, S., Shiffman, M., Kumar, S., Strasser, S., Dore, G., Mcnally, J., Brainard, D., Han, L., Doehle, B., et al (2015). Sofosbuvir plus velpatasvir combination therapy for treatment- Experienced patients with genotype 1 or 3 hepatitis c virus infection: A randomized trial. Annals of Internal Medicine, 163(11), 809-817. [More Information]
• Kitzing, Y., Ng, B., Kitzing, B., Waugh, R., Kench, J., Strasser, S., McCormack, S. (2015). Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population. Journal of Medical Imaging and Radiation Oncology, 59(6), 673-680. [More Information]

2014

• Nguyen, V., Tan, P., Greenup, A., Glass, A., Davison, S., Samarasinghe, D., Holdaway, S., Strasser, S., Chatterjee, U., Jackson, K., et al (2014). Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Alimentary Pharmacology and Therapeutics, 39(10), 1225-1234. [More Information]
• Chinnaratha, M., Chelvaratnam, U., Stuart, K., Strasser, S., McCaughan, G., Gow, P., Adams, L., Wigg, A. (2014). Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders. Liver Transplantation, 20(7), 798-806. [More Information]
• Strasser, S. (2014). Managing hepatitis B to prevent liver cancer: recent advances. Expert Review of Gastroenterology and Hepatology, 8(4), 409-415. [More Information]
• Davison, S., Strasser, S. (2014). Ordering and interpreting hepatitis B serology. BMJ, 348, g2522. [More Information]
• Colombo, M., Fernandez, I., Abdurakhmanov, D., Ferreira, P., Strasser, S., Urbanek, P., Moreno, C., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C. Gut (English Edition): an international journal of gastroenterology and hepatology, 63(7), 1150-1158. [More Information]
• Colombo, M., Strasser, S., Moreno, C., Abrao Ferreira, P., Urbanek, P., Fernandez, I., Abdurakmonov, D., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Sustained Virological Response with Telaprevir in 1078 Patients With Advanced Hepatitis C: The International Telaprevir Access Program. Journal of Hepatology, 61(5), 976-983. [More Information]

2013

• Roberts, D., Hall, M., Falkland, M., Strasser, S., Buckley, N. (2013). Amanita phalloides poisoning and treatment with silibinin in the Australian Capital Territory and New South Wales. Medical Journal of Australia, 198(1), 43-47. [More Information]
• Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Author reply: RE Terlipressin therapy for moderate to severe hyponatraemia in patients with liver failure. Internal Medicine Journal, 43(5), 607-607. [More Information]
• Gane, E., Patterson, S., Strasser, S., McCaughan, G., Angus, P. (2013). Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transplantation, 19(3), 268-274. [More Information]
• Strasser, S. (2013). Hepatocellular carcinoma: The most rapidly rising cause of cancer death in Australia. Medicine Today, 14(12), 55-57.
• Silva, M., Strasser, S., Carrilho, F. (2013). Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma? Clinics, 68(4), 437-440. [More Information]
• Silva, M., Sapisochin, G., Strasser, S., Hewa-Geeganage, S., Chen, J., Wigg, A., Jones, R., Saraiva, R., Kikuchi, L., Carrilho, F., et al (2013). Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysis. European Journal of Surgical Oncology, 39(4), 386-395. [More Information]
• Saunderson, R., Garsia, R., Headley, A., McCaughan, G., O'Toole, S., Strasser, S. (2013). Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. Journal of Dermatological Case Reports, 7(3), 77-81. [More Information]
• Gracey, D., Snelling, P., McKenzie, P., Strasser, S. (2013). Tenofovir-associated Fanconi Syndrome in patients with chronic hepatitis B monoinfection. Antiviral Therapy, 18(7), 945-948. [More Information]
• Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Terlipressin Therapy for Moderate to Severe Hyponatremia in Patients with Liver Failure. Internal Medicine Journal, 43(3), 240-246. [More Information]

2012

• Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012). Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International, 32(10), 1527-1534. [More Information]
• Strasser, S. (2012). Another achievement in organ transplantation in Australia - yet much still needs to be done. Medical Journal of Australia, 197(8), 429-430. [More Information]
• Strasser, S. (2012). Drugs in Development for the Treatment of Chronic Hepatitis B. Current Hepatology Reports, 11(2), 111-118. [More Information]
• Graaf, E., Kench, J., Dilworth, P., Shackel, N., Strasser, S., Joseph, D., Pleass, H., Crawford, M., McCaughan, G., Verran, D. (2012). Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. Journal of Gastroenterology and Hepatology, 27(3), 540-546. [More Information]

2011

• Poustchi, H., Farrell, G., Strasser, S., Lee, A., McCaughan, G., George, J. (2011). Feasibility of conducting a randomised control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology, 54(6), 1998-2004. [More Information]
• Strasser, S., Vidot, H. (2011). Nutritional considerations in end-stage liver disease. Journal of Gastroenterology and Hepatology, 26(9), 1346-1348. [More Information]
• Gidding, H., Law, M., Amin, J., Macdonald, G., Sasadeusz, J., Jones, T., Strasser, S., George, J., Dore, G. (2011). Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Medical Journal of Australia, 194(8), 398-402. [More Information]

2010

• Prakoso, E., Verran, D., Dilworth, P., Kyd, G., Tang, P., Tse, C., Koorey, D., Strasser, S., Stormon, M., Shun, A., Allen, R., et al (2010). Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Internal Medicine Journal, 40(9), 619-625. [More Information]
• Nightingale, S., O'Loughlin, E., Dorney, S., Shun, A., Verran, D., Strasser, S., McCaughan, G., Jermyn, V., Van Asperen, P., Gaskin, K., Stormon, M. (2010). Isolated liver transplantation in children with cystic fibrosis - An Australian experience. Pediatric Transplantation, 14(6), 779-785. [More Information]
• Mahady, S., Carlton, B., FitzGerald, P., Koorey, D., Perry, J., Waugh, R., McCaughan, G., Strasser, S. (2010). Locoregional therapies for hepatocellular carcinoma: Which patients are most likely to gain a survival advantage? Journal of Gastroenterology and Hepatology, 25(7), 1299-1305. [More Information]
• McCaughan, G., Shackel, N., Strasser, S., Dilworth, P., Tang, P. (2010). Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transplantation, 16(2), 130-137. [More Information]
• Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., Locarnini, S., Bowden, S., et al (2010). Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut (English Edition): an international journal of gastroenterology and hepatology, 60(2), 247-254. [More Information]

2009

• Sandroussi, C., Crawford, M., Lockwood, D., Tang, P., Gallagher, J., Pleass, H., Strasser, S., Shackel, N., McCaughan, G., Verran, D. (2009). Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients. Liver Transplantation, 15(11), 1586-1593. [More Information]
• Shackel, N., Jamias, J., Rahman, W., Prakoso, E., Strasser, S., Koorey, D., Crawford, M., Verran, D., Gallagher, J., McCaughan, G. (2009). Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C-Related Liver Failure Post-Liver Transplantation. Liver Transplantation, 15(7), 709-718. [More Information]
• James, M., Strasser, S. (2009). Management of advanced liver disease. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 330-351). East Hawthorn, Victoria: IP Communications.
• Geenen, I., Sosef, M., Shun, A., Crawford, M., Gallagher, J., Strasser, S., Stormon, M., McCaughan, G., Verran, D. (2009). Usage and Outcomes of Deceased Donor Liver Allografts with Preprocurement Injury from Blunt Trauma. Liver Transplantation, 15(3), 321-325. [More Information]

2008

• Angus, P., Patterson, S., Strasser, S., McCaughan, G., Gane, E. (2008). A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis. Hepatology, 48(5), 1460-1466. [More Information]
• Alghamdi, H., Crawford, M., Gallagher, J., McCaughan, G., Strasser, S., Verran, D. (2008). Cadaveric liver transplant from older donors. Saudi Medical Journal, 29(4), 533-538. [More Information]
• Strasser, S. (2008). When should liver biopsy be performed after hematopoietic stem cell transplantation? Journal of Gastroenterology and Hepatology, 23(2), 167-169. [More Information]

2007

• van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
• Labio, E., Del Rosario, D., Strasser, S., McCaughan, G., Crawford, B. (2007). Effect of Ascites on Bone Density Measurement in Cirrhosis. Journal of Clinical Densitometry: Assessment of Skeletal Health, 10(4), 391-394. [More Information]
• Chiong, M., Bennetts, B., Strasser, S., Wilcken, B. (2007). Fatal late-onset ornithine transcarbamylase deficiency after coronary artery bypass surgery. Medical Journal of Australia, 186(8), 418-419. [More Information]
• Perry, J., Charlton, B., Koorey, D., Waugh, R., Gallagher, P., Crawford, M., Verran, D., McCaughan, G., Strasser, S. (2007). Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International, 27(9), 1240-1248. [More Information]

2006

• Salmond, S., George, J., Strasser, S., Batey, R. (2006). Hep573 study of complementary medicine for chronic hepatitis C. Journal Of Clinical Virology, 36(Supplement 2), S134-S135.
• Loss, M., Ng, W., Karim, R., Strasser, S., Koorey, D., Gallagher, P., Verran, D., McCaughan, G. (2006). Hereditary lysozyme amyloidosis: Spontaneous hepatic rupture (15 years apart) in mother and daughter. Role of emeregency liver transplantation. Liver Transplantation, 12(7), 1152-1155. [More Information]
• St George, A., Johnston, A., Bauman, A., Iverson, D., Tapsell, L., McCaughan, G., Strasser, S., McGrath, L., Green, J., Farrell, G., George, J. (2006). Lifestyle intervention in early liver disease: metabolic changes at 3 months. Journal of Gastroenterology and Hepatology, 21(Suppl. 4), A315.
• Prakoso, E., Strasser, S., Koorey, D., Verran, D., McCaughan, G. (2006). Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation, 20(3), 369-373. [More Information]
• Crawford, B., Labio, E., Strasser, S., McCaughan, G. (2006). Vitamin D replacement for cirrhosis-related bone disease. Nature Clinical Practice Gastroenterology and Hepatology, 3(12), 689-699. [More Information]

2005

• Perry, J., Poustchi, H., George, J., Farrell, G., McCaughan, G., Strasser, S. (2005). Current approaches to the diagnosis and management of hepatocellular carcinoma. Clinical and Experimental Medicine, 5(1), 1-13. [More Information]
• McCaughan, G., Koorey, D., Strasser, S. (2005). Liver transplantation for viral hepatitis. British Journal of Hospital Medicine, 66(1), 8-12. [More Information]

2004

• Samuel, D., Riordan, S., Strasser, S., Kurtovic, J., Singh-Grewel, I., Koorey, D. (2004). Severe Autoimmune Hepatitis First Presenting In The Early Post Partum Period. Clinical Gastroenterology and Hepatology, 2(7), 622-624.

2003

• Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., McCaughan, G. (2003). Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplantation, 9(5), 500-505.
• Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive transfer of nut allergy after liver transplantation. Archives of Internal Medicine, 163(2), 237-239.
• Perry, J., Strasser, S., George, J., Farrell, G., McCaughan, G. (2003). Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy, 4(12), 2175-2185.

2002

• McCaughan, G., Koorey, D., Strasser, S. (2002). Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal, 32(8), 394-400.